Discover the Vielight Neuro-Vagus combo, a pioneering system that merges brain stimulation with vagus nerve stimulation to enhance brain function, systemic performance, and brain-body connectivity. Additionally, the world-exclusive Vielight Neuro Duo offers transcranial-intranasal photobiomodulation (PBM) for cognitive, memory, and blood flow improvements.
As the world’s only transcranial-intranasal brain photobiomodulation (PBM) device, the Vielight Neuro Duo is is the result of years of engineering and research.
Clinical research with our technology has produced improvements in cognition, memory and blood flow.
The Vielight Neuro Duo comes with both Alpha and Gamma modes.
Vielight technology quality is guaranteed by medical grade certification.
Unlock Your Brain's Potential with the Vielight Neuro Duo
The Vielight Neuro Duo represents a powerful and extensively researched brain photobiomodulation (tPBM) device, featuring cutting-edge intranasal technology. It's designed to be safe, effective, and exceptionally user-friendly, offering the potential to unlock your brain's capabilities. Our patented transcranial-intranasal technology provides a unique and potent approach to stimulating the Default Mode Network in the brain.
The Neuro Duo emits pulsed near-infrared (NIR) energy through the cranium, initiating the process of photobiomodulation. Our engineering prowess allows us to extract one of the highest levels of power (~100 mW/cm2) from a near-infrared LED energy source, all while ensuring there is no heat generated.
This innovative device operates at two crucial frequencies:
Choose the Vielight Neuro Duo to embark on a journey of brain stimulation, where you can potentially experience amplified focus, cognitive performance, memory enhancement, relaxation, and better sleep. Our rigorous research and cutting-edge technology combine to offer you a powerful tool to tap into your brain's potential.
Why the nose?
Being just 3 inches from the brain, the intranasal channel is the most efficient channel for photobiomodulation of the ventral (underside) brain area. These ventral structures within the brain’s core have important functions.
Engineering behind the Vielight Neuro.
The Vielight Neuro enables direct contact with the scalp’s surface to maximize energy transmission and penetration while microchip-boosted cold LED diodes generate substantial power without releasing heat. Additionally, our patented intranasal technology enables photobiomodulation of the ventral brain areas.
Vielight Neuro – NIR light energy penetration.
Effects of the Vielight Neuro.
Default-mode network activity in
the PBM group—(A) baseline and (B) week
12 and in the usual care group—(C) baseline and (D) week 12. The posterior cingulate cortex (1, -61, and 38) was used as
seed in the analysis
Comparing EEG Power Spectrum:
Active vs Sham tPBM Using Non-Parametric Cluster-Based Permutation Test.
Non-parametric cluster-based permutation test comparing the rest EEG power spectrum between active and sham tPBM. Topographical maps are color-coded according to the permutation tests t-values. Clusters of electrodes with significant difference between the two conditions are marked in ‘+’ sign (p < 0.05 and αcluster = 0.01). (a) Difference between post and pre active tPBM. (b) Difference between post and pre sham tPBM. (c) Difference between pre active and sham tPMB. (d) Difference between post active and sham tPMB.
tPBM's Impact on Resting-State EEG:
Active vs Sham Stimulation Compared by Frequency Bands.
Influence of tPBM on resting-state electroencephalography. Box plot illustrates the median and range of power spectrum across all electrodes for each oscillatory frequency bands. (a) Effect of active tPBM on power spectrum pre (green line) and post (red line). (b) Effect of sham tPBM on power spectrum pre (green line) and post (red line). (c) Difference between Active and Sham tPBM: Change of power spectrum Post-Pre for active (red line) and sham (green line) tPBM. Active versus sham stimulation revealed significant lower alteration in delta and theta power and higher change in alpha, beta and gamma frequency bands.
Product Features:
- Optimal Stimulation: Uses NIR energy for effective brain and vagal nerve stimulation.
- Advanced Engineering:High irradiance with minimal heat production.
- Dual Modes: Alpha (10Hz) for relaxation and sleep; Gamma (40Hz) for focus, memory, and energy.
- Medical Grade: Quality guaranteed with medical certification.
- Enhanced cognition and memory.
- Improved systemic performance and brain-body connection.
- Regulation of heart rate, digestion, immune responses, and mood.
- Free Consultation: Available before and after purchase.
- Warranty:2-year manufacturer’s warranty for peace of mind.
- Shipping: Depots in the USA, with Delivery times range from 2-14 business days.
- Returns: 6-months, no-questions-asked return policy, offering 80% refund.
Important Note:To ensure customer satisfaction and support, warranty and returns only apply to purchases made through authorized channels—devices bought through unauthorized sellers like Amazon and eBay are excluded.
The Vielight Vagus enables non-invasive vagus nerve stimulation (VNS) via photobiomodulation (PBM). This device was engineered to enhance brain-body connectivity via the vagus nerve.
The Vielight Vagus can be used together with the Vielight Neuro to complement and maximize outcomes.
Why the vagus nerve?
The vagus nerve is crucial in regulating many of our bodies’ most basic functions. One of the most important aspects of the vagus nerve is its direct connection between the brain and the gut.
Neuroplasticity: VNS has been associated with promoting changes in the brain’s structure and function, improving connectivity and neural network efficiency.
Cognitive Enhancement: Studies have explored the impact of VNS on cognitive functions. Some findings suggest improvements in memory, attention, and other cognitive domains.
Inflammation and Health: VNS has also been investigated for its potential effects on reducing inflammation and improving overall health outcomes.
Manufacturer |
Vielight Inc |
---|---|
LED Power |
1000 mW per module |
Power Density | Irradiance |
100-150 mW/cm² (3) : Rear Transcranial LEDs |
Est. Irradiance Area |
400cm² (+/- 50cm²) including Intranasal module footprint |
Targeted Brain Network |
Default Mode Network |
Head Size Suitability |
Minimum age: 5 years old based on published study data |
Medical Grade Certification |
ISO13485 and MDSAP |
Safety Certification |
TÜV Rheinland |
Warranty |
24 months |
Satisfaction Guarantee |
We have an 80% refund policy, valid for 6 months from the time of purchase |
Manufacturer |
Vielight Inc |
---|---|
LED Power |
500 mW per module |
Power Density | Irradiance |
50 mW/cm² (2) : Bilateral LEDs |
Est. Irradiance Area |
400cm² (+/- 50cm²) including Intranasal module footprint |
Medical Grade Certification |
ISO13485 and MDSAP |
Safety Certification |
TÜV Rheinland |
Warranty |
24 months |
Satisfaction Guarantee |
We have an 80% refund policy, valid for 6 months from the time of purchase |
This product includes an intranasal applicator for enhanced delivery and effectiveness.
Condition | Topic | Institution | Vielight Device | Research Type | Status |
---|---|---|---|---|
|
University of California San Francisco | US Veterans Affairs | Vielight Neuro Gamma | Clinical Study | Completed |
|
Harvard Medical School | Boston University School of Medicine | Vielight Neuro Gamma | Clinical Study | Completed |
|
Unity Health, Toronto | Vielight Neuro Gamma | Clinical Study | Analysis Stage |
|
University of Florida | University of Arizona | National Institute on Aging | Vielight 810 [MIP] | Phase 2 Clinical Trial (n=168) | Ongoing |
|
St Michael’s Hospital | Vielight Inc | Vielight Neuro Gamma | Phase 3 Clinical Trial (n=228) |
Ongoing |
|
University of California San Francisco | US Veterans Affairs | Vielight Neuro Gamma | Clinical Study | Results Analysis |
|
Department of Neurology, University of Utah | Vielight Neuro Gamma | Clinical Trial (n=49) | Pre-publication |
|
Boston University School of Medicine | Harvard Medical School | Vielight Neuro Gamma | Clinical Study | Completed |
|
VA Advanced Imaging Research Center, San Francisco VA Health Care System | Vielight Neuro Gamma | Clinical Study | Completed |
|
Boston Veterans Affairs Research Institute | Vielight Neuro Gamma | Clinical Study | Ongoing |
|
University of Sydney | Vielight Neuro Gamma | Clinical Study | Completed |
|
University of Florida | Vielight 810 [MIP] | Phase 2 Clinical trial (n=135) | Ongoing |
|
University of Sydney | University of Brisbane | Vielight Neuro Gamma | Clinical Study | Registered |
|
University of California San Francisco | US Veterans Affairs | Vielight Neuro Alpha | Clinical Study | Completed |
|
Neurodevelopment Division, Istituto di Neuroscienze, Italy | Vielight Neuro Duo | Clinical Study | Completed |
|
Vielight Inc | Vielight RX Plus | Pivotal Phase 3 Clinical Trial (n=295) | Completed |
|
University of Toronto | Vielight Inc | Vielight Neuro Gamma | Clinical Study | Completed |
|
Vielight Inc | Vielight Neuro Alpha | Clinical Study | Pre- Publication |
|
Princeton University | University of Alberta | Vielight Inc | Vielight Neuro Alpha | Research Study | Completed |
|
Vielight Inc | Vielight RX Plus | Pivotal Phase 3 Clinical Trial (n=295) | Completed |
|
Harvard Medical School | Vielight Blue [MIP] | Scientific Study | Completed |
|
Harvard Medical School | Vielight Blue [MIP] | Scientific Study | Completed |
|
Harvard Medical School | Vielight Blue [MIP] | Scientific Study | Completed |
|
University of Deusto, Spain | University of Montpellier, France | Pennsylvania State University | Vielight Neuro Gamma | Clinical Research (n=56) | Completed |
|
University of Alberta | Polytechnic University of Turin | Vielight Neuro Alpha | Scientific Study | Completed |
Effects of Home Photobiomodulation Treatments on Cognitive and Behavioral Function and Resting-State Functional Connectivity in Patients with Dementia: A Pilot Trial
Institutes – University of California San Francisco & the Veterans Affairs USA
[ Published Study Device: Vielight Neuro Gamma ]
Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report
Co-authoring institutes – Harvard Medical School, Boston University School of Medicine
[ Published Study | Device: Vielight Neuro Gamma ]
Vielight Neuro RX Gamma – Alzheimer’s Disease Pivotal Phase III Clinical Trial (n=228)
Co-institutes – St Michael’s Hospital, Toronto
[ Clinical Trial Information Link ] (228 participants | 3 years | Ongoing)
Neuro RX Gamma for Amnestic Mild Cognitive Impairment (aMCI) / Dementia
Co-institutes – Unity Health Toronto, Toronto
[ Clinical Trial Information Link | Device: Vielight Neuro Gamma ]
Revitalizing Cognition in Older Adults at Risk for Alzheimer’s Disease With Near-Infrared Photobiomodulation
Institutes – University of Florida, University of Arizona, National Institute on Aging (NIA)
[ Clinical Trial Information Link | Device: Vielight Neuro Gamma ] (168 participants | 5 years | Registration)
Impact of Photobiomodulation (PBM) on Biomarkers of Alzheimer’s Disease
Institutes – University of California San Francisco UCSF
[ Clinical Trial Information Link / Device: Vielight Neuro Gamma ] (16 participants | 1.5 years | Ongoing)
Transcranial Photobiomodulation Treatment Effects In Former Athletes With Repetitive Head Hits (n=49)
Institutes – Department of Neurology, University of Utah
[ Published Abstract Link | Device: Vielight Neuro Gamma ] (49 participants | Pending publication)
Transcranial Photobiomodulation Treatment: Significant Improvements in Four Ex-Football Players with Possible Chronic Traumatic Encephalopathy
Institutes – Boston University School of Medicine, Harvard Medical School
[ Published Study Link | Device: Vielight Neuro Gamma ]
Changes in Brain Function and Structure After Self-Administered Home Photobiomodulation Treatment in a Concussion Case
Institutes – VA Advanced Imaging Research Center, San Francisco VA Health Care System, Departments of Radiology & Biomedical Imaging and Psychiatry & Behavioral Sciences, University of California, San Francisco
[ Published Study Link | Device: Vielight Neuro Gamma ]
Photobiomodulation to Improve Cognition in TBI, With fMRI
Institutes – Boston Veterans Affairs Research Institute
[ Clinical Trial Information Link | Device: Vielight Neuro Gamma ] (20 participants | 1 years | Ongoing)
Improvements in clinical signs of Parkinson’s disease using photobiomodulation: A prospective proof-of-concept study
Institutes – University of Sydney, University of New South Wales, Griffith University
[ Published Study Link Device: Vielight Neuro Gamma ]
Pilot Intervention With Near Infrared Stimulation
Institutes – University of Florida
[ Clinical Trial Information Link | Device: Vielight Neuro Gamma ] (135 participants | 4 years | Ongoing)
Evaluation of dose of Photobiomodulation (Light) Therapy and Physiotherapy for Improving Quality of Life Outcomes and Mobility in Parkinson’s Disease (Pilot)
Institutes – University of Sydney, University of Brisbane
[ Clinical Trial Information Link | Device: Vielight Neuro Gamma ] (16 participants | 1.5 years | Ongoing)
Improvements in Gulf War Illness Symptoms After Near-Infrared Transcranial and Intranasal Photobiomodulation: Two Case Reports
Institutes – University of California San Francisco & the Veterans Affairs USA
[ Published Study Link | Device: Vielight Neuro Alpha ]
Transcranial Photobiomodulation for the Treatment of Children with Autism Spectrum Disorder (ASD): A Retrospective Study
Institutes – Neurodevelopment Division, Istituto di Neuroscienze, Italy, Department of Psychiatry, Albert Einstein College of Medicine, NY
[ Published Study Link Device: Vielight Neuro Duo ]
Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms
Various clinical sites
[ Pre-print of Results ] (295 participants | 1 year | Pre-publication)
A Pilot Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment
Various clinical sites
[ Clinical Trial Information ] (36 participants | 1 year | Recruitment)
Enhancement of Divergent Creative Thinking After Transcranial Near-Infrared Photobiomodulation Over the Default Mode Network
Institutes – University of Deusto | University of Montpellier | Pennsylvania State University
[ Published Study Link Device: Vielight Neuro Gamma ]
Pulsed Near Infrared Transcranial and Intranasal Photobiomodulation Significantly Modulates Neural Oscillations: a pilot exploratory study
Institutes – Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
[ Published Study Link (Nature, Scientific Reports, 2019) | Device: Vielight Neuro Gamma ]
Modulation of cortical oscillations using 10hz near-infrared transcranial and intranasal photobiomodulation: a randomized sham-controlled crossover study
[ Abstract Text Link | Device: Vielight Neuro Alpha ]
Near-Infrared Photobiomodulation of Living Cells, Tubulin, and Microtubules In Vitro
Institutes – Department of Physics and the Department of Chemistry, University of Alberta | Scholes Lab, Department of Chemistry, Princeton University, Princeton, NJ, United States | Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy | Vielight Inc
[ Published Study Link | Device: Vielight Neuro Alpha ]
Raman Spectroscopy Reveals Photobiomodulation-Induced α-Helix to β-Sheet Transition in Tubulins: Potential Implications for Alzheimer’s and Other Neurodegenerative Diseases
Institutes – University of Alberta, Polytechnic University of Turin, Freie Universit¨at Berlin, Silesian University of Technology
[ Pre-print | Device: Vielight Neuro Alpha ]
Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms
Various clinical sites
[ Pre-print of Results ] (295 participants | 1 year | Pre-publication)
Antimicrobial Photodynamic Inactivation Mediated by Tetracyclines in Vitro and in Vivo: Photochemical Mechanisms and Potentiation by Potassium Iodide
Institutes – Harvard Medical School
[ Published Study Link | Vielight MIP ]
Antimicrobial Blue Light Therapy for Infectious Keratitis: Ex Vivo and In Vivo Studies
Institutes – Harvard Medical School
[ Published Study Link | Vielight MIP ]
Antimicrobial blue light inactivation of Candida albicans: In vitro and in vivo studies
Institutes – Harvard Medical School
[ Published Study Link | Vielight MIP ]
Thanks for visiting our website. We value your time and are always happy to help. Please fill out the contact form below with your name, email address, and message, and we'll get back to you as soon as possible.
We look forward to hearing from you and assisting with any questions or concerns you may have.